Phylos Raises $25.1 Million for Protein Chip Effort | GenomeWeb

NEW YORK, Jan 4 - Phylos, a privately held proteomics company that wants to develop the first high-throughput protein chip, announced Thursday that it had raised $25.1 million in a round of private financing.

The Lexington, Mass.-based company's principal investors include Three Arch Partners, Sprout Group, Lone Pine Capital, and Invemed Associates.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.